Loinaz C et al. |
A single-centre experience with cyclosporine microemulsion versus tacrolimus in 100 randomized liver transplant recipients: midterm efficacy and safety. |
2001 Nov-Dec |
Transplant. Proc. |
pmid:11750472
|
Tolba RH et al. |
Conversion to Neoral for tacrolimus-related adverse effects in liver transplant recipients and improvement in quality of life. |
2001 Nov-Dec |
Transplant. Proc. |
pmid:11750475
|
Rostaing L et al. |
Early posttransplantation renal hemodynamics in FK 506-treated kidney recipients with or without prior induction therapy. |
1998 |
Transplant. Proc. |
pmid:9636519
|
Rostaing L et al. |
Influence of early FK 506 trough levels on glomerular hemodynamics at 3 months in kidney transplant recipients. |
1998 |
Transplant. Proc. |
pmid:9636520
|
Hu RH et al. |
Clinical influencing factors for daily dose, trough level, and relative clearance of tacrolimus in renal transplant recipients. |
2000 |
Transplant. Proc. |
pmid:11119894
|
Kamińska D et al. |
Significant infections after hand transplantation in a Polish population. |
2014 |
Transplant. Proc. |
pmid:25380943
|
Marin-Gomez LM et al. |
Evaluation of clinical safety of conversion to Advagraf therapy in liver transplant recipients: observational study. |
2009 Jul-Aug |
Transplant. Proc. |
pmid:19715867
|
Aktürk S et al. |
Pregnancy After Kidney Transplantation: Outcomes, Tacrolimus Doses, and Trough Levels. |
2015 |
Transplant. Proc. |
pmid:26093738
|
Shoji T et al. |
Long-term acceptance of porcine pulmonary allografts without chronic rejection. |
2005 Jan-Feb |
Transplant. Proc. |
pmid:15808551
|
Kinoshita I et al. |
Immunosuppression with FK 506 insures good success of myoblast transplantation in MDX mice. |
1994 |
Transplant. Proc. |
pmid:7527978
|
Ortiz de Urbina J et al. |
Advagraf de novo in liver transplantation: a single-center experience. |
2011 |
Transplant. Proc. |
pmid:21486583
|
Reggiani P et al. |
Conversion to rescue therapy with FK 506: data from eight liver transplant patients. |
1994 |
Transplant. Proc. |
pmid:7527982
|
Porayko MK et al. |
Nephrotoxicity of FK 506 and cyclosporine when used as primary immunosuppression in liver transplant recipients. |
1993 |
Transplant. Proc. |
pmid:7679835
|
Iwasaki K et al. |
Pharmacokinetic study of FK 506 in the rat. |
1991 |
Transplant. Proc. |
pmid:1721268
|
Andersson J et al. |
FK 506 and cyclosporine inhibit antigen- or mitogen-induced monokine and lymphokine production in vitro. |
1992 |
Transplant. Proc. |
pmid:1371621
|
Takada S et al. |
HGF prevents tacrolimus (FK 506)-induced nephrotoxicity in SHR rats. |
1996 |
Transplant. Proc. |
pmid:8623236
|
Murase N et al. |
Induction of liver, heart, and multivisceral graft acceptance with a short course of FK 506. |
1990 |
Transplant. Proc. |
pmid:1689906
|
Qu W et al. |
Correlation Between Immunosuppressive Therapy and CD4(+) T-Cell Intracellular Adenosine Triphosphate Levels in Liver Transplant Recipients. |
|
Transplant. Proc. |
pmid:27569951
|
Steinmueller T et al. |
Effect of CsA versus FK 506 on insulin sensitivity and insulin response using a modeling technique. |
1998 |
Transplant. Proc. |
pmid:9636589
|
Miura S et al. |
The beneficial effects of FK 506 on living-related renal transplantation in presensitized recipients. |
1999 |
Transplant. Proc. |
pmid:10455940
|
Hossain MA et al. |
Effect of the immunosuppressants FK506 and D-allose on allogenic orthotopic liver transplantation in rats. |
2000 |
Transplant. Proc. |
pmid:11120048
|
Ali MN et al. |
Case series: hemolytic uremic syndrome--another cause of transplant dysfunction. |
2013 |
Transplant. Proc. |
pmid:24182801
|
Kliem V et al. |
Conversion to tacrolimus for acute corticosteroid- and antibody-resistant rejection following kidney transplantation. |
1999 |
Transplant. Proc. |
pmid:10576041
|
Friemann S et al. |
Conversion to tacrolimus in hyperlipidemic patients. |
1999 |
Transplant. Proc. |
pmid:10576042
|
Gonzalez-Molina M et al. |
Mycophenolate mofetil and tacrolimus reduce mortality after deceased donor kidney transplantation. |
2012 |
Transplant. Proc. |
pmid:23146459
|
Batista F et al. |
Long-term follow-up after conversion from tacrolimus to cyclosporin in renal transplant patients with new-onset diabetes mellitus after transplantation. |
2012 |
Transplant. Proc. |
pmid:23146461
|
Yeung S et al. |
Primary immunosuppression with tacrolimus and low-dose mycophenolate mofetil in renal transplant recipients. |
2004 |
Transplant. Proc. |
pmid:15518754
|
Hu RH et al. |
Effects of and predictors for tacrolimus rescue therapy among renal transplant patients under cyclosporine-based immunosuppression. |
2004 |
Transplant. Proc. |
pmid:15518757
|
Alloway RR et al. |
Conversion from cyclosporine to tacrolimus in kidney, kidney/pancreas, and pancreas alone transplant recipients: the Memphis experience. |
1996 |
Transplant. Proc. |
pmid:8623494
|
Dumont FJ et al. |
Up-regulation of gene expression by FK 506. |
1991 |
Transplant. Proc. |
pmid:1721300
|
Woodle ES et al. |
Role of protocol biopsies in the treatment of refractory renal allograft rejection with FK 506. |
1996 |
Transplant. Proc. |
pmid:8623495
|
Rao P et al. |
Effect of FK 506 on FK-binding protein and transforming growth factor beta gene expression. |
1991 |
Transplant. Proc. |
pmid:1721301
|
Curro G et al. |
Transient ischemic attack after rizatriptan administration in a liver transplant recipient: a case report. |
2006 |
Transplant. Proc. |
pmid:17112920
|
Uchida H et al. |
Experimental intestinal transplantation using mouse fetal intestine in the rat: combination effect of FK 506 with cyclophosphamide. |
1999 |
Transplant. Proc. |
pmid:10578297
|
Wasilewski G et al. |
Inadequate blood pressure control in orthotopic heart transplant: is there a role of kidney function and immunosuppressive regimen? |
2014 |
Transplant. Proc. |
pmid:25380929
|
Jin KB et al. |
The production of reactive oxygen species in tacrolimus-treated glial cells. |
2008 |
Transplant. Proc. |
pmid:18929834
|
Chung YW et al. |
Transcriptional activation of nuclear-related factor 2 by FK506 in Jurkat T cells. |
2015 |
Transplant. Proc. |
pmid:25891728
|
Benedini S et al. |
Glucose and leucine metabolism in lung tranplanted patients on low dose of steroids for immunosuppressive therapy. |
2008 |
Transplant. Proc. |
pmid:18589153
|
Takara T et al. |
Intraportal donor-specific transfusion given 24 hours before small bowel transplantation with cyclosporine and FK 506. |
1994 |
Transplant. Proc. |
pmid:7518150
|
Jain A et al. |
Intravenous, oral pharmacokinetics, and oral dosing of FK 506 in small bowel transplant patients. |
1992 |
Transplant. Proc. |
pmid:1376518
|
Watanabe K et al. |
Factors influencing long-term operational tolerance in dogs treated with fractionated lymphoid irradiation, donor bone marrow cell infusion and FK506. |
1995 |
Transplant. Proc. |
pmid:7533389
|
Borg AJ and Kumagai M |
FK 506 and xenogeneic human anti-porcine cellular reactivity. |
1991 |
Transplant. Proc. |
pmid:1721332
|
Lladó L et al. |
Prospective study of a tacrolimus-based quadruple immunosuppressive regimen: evaluation of safety and efficacy. |
2002 |
Transplant. Proc. |
pmid:12176468
|
Serrano J et al. |
Tacrolimus is effective in both dual and triple regimens after liver transplantation. |
2002 |
Transplant. Proc. |
pmid:12176469
|
Fleck PR et al. |
Tacrolimus use in kidney-pancreas recipients is associated with less acute renal dysfunction than cyclosporine. |
1998 |
Transplant. Proc. |
pmid:9865299
|
du Toit DF et al. |
Tacrolimus (FK506) monotherapy provides potent and significant suppression of allogeneic foetal rat pancreatic allograft rejection. |
1998 |
Transplant. Proc. |
pmid:9865300
|
Krämer BK et al. |
Cardiovascular risk estimates and risk factors in renal transplant recipients. |
2005 |
Transplant. Proc. |
pmid:15919488
|
Regazzi MB et al. |
Pharmacokinetics of FK506 and mycophenolic acid in experimental and clinical intestinal transplantation. |
1997 |
Transplant. Proc. |
pmid:9142302
|
Hansen LJ et al. |
Early pharmacokinetic profiles of enteral tacrolimus after multivisceral transplantation. |
1997 |
Transplant. Proc. |
pmid:9142303
|
Moro JA et al. |
Randomized prospective study of the evolution of renal function depending on the anticalcineurin used. |
2008 |
Transplant. Proc. |
pmid:19010143
|
Fukuhara N et al. |
Long-term outcome of tacrolimus in cadaveric kidney transplantation from non-heart-beating donors. |
2002 |
Transplant. Proc. |
pmid:12176492
|
Barrera-Pulido L et al. |
Clinical relevance and prevalence of polymorphisms in CYP3A5 and MDR1 genes that encode tacrolimus biotransformation enzymes in liver transplant recipients. |
2008 |
Transplant. Proc. |
pmid:19010156
|
Tanabe K et al. |
Outcome of kidney transplantation from non-heart-beating donors followed by tacrolimus immunosuppression in japan. |
2002 |
Transplant. Proc. |
pmid:12176493
|
Gruttadauria S et al. |
Basiliximab in a triple-drug regimen with tacrolimus and steroids in liver transplantation. |
2005 Jul-Aug |
Transplant. Proc. |
pmid:16182762
|
Lemster B et al. |
Cytokine gene expression in murine lymphocytes activated in the presence of FK 506, bredinin, mycophenolic acid, or brequinar sodium. |
1992 |
Transplant. Proc. |
pmid:1281576
|
Tze WJ et al. |
FK 506: an effective immunosuppressant for islet xenotransplantation. |
1992 |
Transplant. Proc. |
pmid:1281577
|
Gojowy D et al. |
High Frequency of Arterial Hypertension in Patients After Liver Transplantation. |
2016 |
Transplant. Proc. |
pmid:27496479
|
Jordan ML et al. |
FK 506 conversion of renal allografts failing cyclosporine immunosuppression. |
1991 |
Transplant. Proc. |
pmid:1721365
|
Wilusz M et al. |
Effects of Immunosuppressive Drugs on Serum Fatty Acids of Phospholipids Fraction in Renal Transplant Recipients. |
2016 |
Transplant. Proc. |
pmid:27496457
|
Alessiani M et al. |
Infections in adult liver transplant patients under FK 506 immunosuppression. |
1991 |
Transplant. Proc. |
pmid:1703345
|
Yamauchi M et al. |
Effects of FK506 on rat thymic microenvironment in thymocyte maturation, proliferation, and mobilization. |
1998 |
Transplant. Proc. |
pmid:9838578
|
Mueller AR et al. |
Is the use of marginal liver grafts justified? |
1999 Feb-Mar |
Transplant. Proc. |
pmid:10083160
|
Miki T et al. |
Xenogeneic humoral graft-Vs-host disease following hamster-to-Rat bone marrow transplantation. |
2000 |
Transplant. Proc. |
pmid:10936339
|
Zipperle S et al. |
Impaired T-cell IL-10 secretion and CD4 helper function in liver transplant patients treated with tacrolimus. |
1997 Feb-Mar |
Transplant. Proc. |
pmid:9123208
|
Chien YS et al. |
Incidence and risk factors of new-onset diabetes mellitus after renal transplantation. |
2008 |
Transplant. Proc. |
pmid:18790250
|
Moons P et al. |
Steroids may compromise quality of life of renal transplant recipients on a tacrolimus-based regimen. |
2002 |
Transplant. Proc. |
pmid:12176538
|
Sharma A et al. |
Incidence of glucose metabolic abnormalities in Indian living renal allograft recipients on tacrolimus-based triple drug immunosuppression. |
2008 |
Transplant. Proc. |
pmid:18790252
|
Sato K et al. |
Pancreaticoduodenal allotransplantation with cyclosporine and FK506. |
1989 |
Transplant. Proc. |
pmid:2468212
|
Freise CE et al. |
Similar clinical presentation of neurotoxicity following FK 506 and cyclosporine in a liver transplant recipient. |
1991 |
Transplant. Proc. |
pmid:1721397
|
Gu B et al. |
Exploration of Fecal Microbiota Transplantation in the Treatment of Refractory Diarrhea After Renal Transplantation. |
2018 |
Transplant. Proc. |
pmid:29880353
|
Gasser M et al. |
Putative regulatory function of alloreactive Th2 cells in tolerant recipients after small bowel transplantation. |
2001 Feb-Mar |
Transplant. Proc. |
pmid:11266759
|
Nakao A et al. |
Changes of allo-intestinal graft survival and intragraft cytokine expression by bone marrow augmentation with tacrolimus treatment in rats. |
2001 Feb-Mar |
Transplant. Proc. |
pmid:11266851
|
Jiang H et al. |
Inhibition of IL-10 by FK 506 may be responsible for overcoming ongoing allograft rejection in the rat. |
1999 Feb-Mar |
Transplant. Proc. |
pmid:10083538
|
Alessiani M et al. |
Correlations between functional changes and different grades of acute rejection in swine small bowel allografts. |
2000 |
Transplant. Proc. |
pmid:10995933
|
Kahan BD |
High variability of drug exposure: a biopharmaceutic risk factor for chronic rejection. |
1998 |
Transplant. Proc. |
pmid:9723224
|
Weir MR |
Optimizing early de novo immunosuppression with sirolimus. |
2008 |
Transplant. Proc. |
pmid:19100903
|
Chang HR et al. |
Sirolimus addition is beneficial for renal allograft dysfunction due to simultaneous acute rejection episode and calcineurin inhibitor nephrotoxicity. |
2004 |
Transplant. Proc. |
pmid:15621119
|
Khwaja K et al. |
Pancreas transplantation in cross-match-positive recipients using cyclosporine- or tacrolimus-based immunosuppression. |
2002 |
Transplant. Proc. |
pmid:12176621
|
Fukuzawa M et al. |
Effect of donor-specific transfusion and FK 506 on small intestine allotransplantation. |
1991 |
Transplant. Proc. |
pmid:1721427
|
Park KM et al. |
Bone loss after orthotopic liver transplantation: FK 506 versus cyclosporine. |
1996 |
Transplant. Proc. |
pmid:8658863
|
Venkataramanan R et al. |
Biopharmaceutical aspects of FK-506. |
1987 |
Transplant. Proc. |
pmid:2445070
|
Ishikawa S et al. |
Management of Juvenile Idiopathic Arthritis in ABO-incompatible Kidney Transplantation: A Case Report. |
2018 |
Transplant. Proc. |
pmid:29661455
|
Chakrabarti P et al. |
Outcome after steroid withdrawal in adult renal transplant patients receiving tacrolimus-based immunosuppression. |
2001 Feb-Mar |
Transplant. Proc. |
pmid:11267274
|
Fukuoka N et al. |
Micafungin does not influence the concentration of tacrolimus in patients after allogeneic hematopoietic stem cell transplantation. |
2010 |
Transplant. Proc. |
pmid:20832577
|
Xu M et al. |
FTY720 compares with FK 506 as rescue therapy in rat heterotopic cardiac transplantation. |
1998 |
Transplant. Proc. |
pmid:9723447
|
Maroun T et al. |
Rejection therapy with tacrolimus in renal transplantation: preliminary results of a collaborative multicenter study in 45 patients. Groupe Cooperatif de Transplantation D'ile de France (GCIF). |
1998 |
Transplant. Proc. |
pmid:9745576
|
Pirsch JD |
Mycophenolate mofetil, tacrolimus, Neoral: from clinical trials to the clinic. |
1998 |
Transplant. Proc. |
pmid:9723448
|
Antoine C et al. |
Vascular microthrombosis in renal transplant recipients treated with tacrolimus. |
1998 |
Transplant. Proc. |
pmid:9745577
|
Ito Y et al. |
Complete replacement of tracheal epithelia by the host promotes spontaneous acceptance of orthotopic tracheal allografts in rats. |
2004 |
Transplant. Proc. |
pmid:15561264
|
Kiji T et al. |
Relationship between immunological rejection and matrix GLA protein in cryopreserved vascular allografts. |
2004 |
Transplant. Proc. |
pmid:15561265
|
Fung JJ and Starzl TE |
FK 506 in solid organ transplantation. |
1994 |
Transplant. Proc. |
pmid:7524226
|
McCauley J et al. |
FK 506 in the management of transplant-related nephrotic syndrome and steroid-resistant nephrotic syndrome. |
1991 |
Transplant. Proc. |
pmid:1721459
|
Carrieri G et al. |
Effect of FK 506 in the prophylaxis of autoimmune glomerulonephritis in NZB/WF1 mice. |
1991 |
Transplant. Proc. |
pmid:1721460
|
Griffin AD et al. |
FK 506 in canine renal transplantation. |
1992 |
Transplant. Proc. |
pmid:1384209
|
Owen ER et al. |
Peripheral nerve regeneration in human hand transplantation. |
2001 Feb-Mar |
Transplant. Proc. |
pmid:11267484
|
Ben-Ari Z et al. |
Conversion of liver allograft recipients from cyclosporine A to FK 506 immunosuppressive therapy. |
2000 |
Transplant. Proc. |
pmid:10856553
|
Stempfle HU et al. |
Rapid trabecular bone loss after cardiac transplantation using FK506 (tacrolimus)-based immunosuppression. |
1998 |
Transplant. Proc. |
pmid:9636459
|
Wojciechowski D et al. |
Mycophenolate Mofetil Withdrawal With Conversion to Everolimus to Treat BK Virus Infection in Kidney Transplant Recipients. |
2017 |
Transplant. Proc. |
pmid:28923623
|
Nanmoku K et al. |
Effective and Safe Reduction of Conventional Immunosuppressants Using Everolimus in Maintenance Kidney Transplant Recipients. |
2017 |
Transplant. Proc. |
pmid:28923615
|
Ericzon BG et al. |
Effect of FK 506 on glucose metabolism in the cynomolgus monkey: studies in pancreatic transplant recipients and nontransplanted animals. |
1991 |
Transplant. Proc. |
pmid:1703695
|